Literature DB >> 15386669

Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.

Gerald Richardson1, Andrea Manca.   

Abstract

Economic evaluations alongside randomised controlled trials (RCTs) are increasingly being designed to prospectively collect patient-specific resource use and preference-based health status (utility) data. This paper examines the ways in which preference-based health status (utility) data are used to generate quality adjusted life years (QALYs). A literature review was carried out which identified 23 published cost utility analyses suitable for inclusion. The methodology employed to calculate QALYs was not always consistent, as well as being poorly reported. The use of different methodologies in the calculation of QALYs may influence the magnitude and direction of results of evaluations. Analysts need to be consistent and fully transparent in the methodology chosen to calculate QALYs. 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15386669     DOI: 10.1002/hec.901

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  57 in total

1.  Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT).

Authors: 
Journal:  BMJ       Date:  2005-09-10

2.  The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee.

Authors:  Veerle M H Coupé; Cindy Veenhof; Maurits W van Tulder; Joost Dekker; Johannes W J Bijlsma; Cornelia H M Van den Ende
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

3.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation.

Authors:  Christine M McDonough; Tor D Tosteson; Anna N A Tosteson; Alan M Jette; Margaret R Grove; James N Weinstein
Journal:  Med Decis Making       Date:  2010-11-22       Impact factor: 2.583

5.  Methodological reviews of economic evaluations in health care: what do they target?

Authors:  Maria-Florencia Hutter; Roberto Rodríguez-Ibeas; Fernando Antonanzas
Journal:  Eur J Health Econ       Date:  2013-08-24

6.  The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.

Authors:  Paul A Scuffham; Jennifer A Whitty; Andrew Mitchell; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 7.  An educational review of the statistical issues in analysing utility data for cost-utility analysis.

Authors:  Rachael Maree Hunter; Gianluca Baio; Thomas Butt; Stephen Morris; Jeff Round; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

8.  Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond; Anthony Scott
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

9.  Bayesian variable selection in cost-effectiveness analysis.

Authors:  Miguel A Negrín; Francisco J Vázquez-Polo; María Martel; Elías Moreno; Francisco J Girón
Journal:  Int J Environ Res Public Health       Date:  2010-04-06       Impact factor: 3.390

10.  Cost effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET).

Authors:  Gerry Richardson; Karen Bloor; John Williams; Ian Russell; Dharmaraj Durai; Wai Yee Cheung; Amanda Farrin; Simon Coulton
Journal:  BMJ       Date:  2009-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.